These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25383135)

  • 1. Chronic urticaria: new management options.
    Greenberger PA
    World Allergy Organ J; 2014; 7(1):31. PubMed ID: 25383135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic autoimmune urticaria with omalizumab.
    Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Urticaria: An Overview of Treatment and Recent Patents.
    Hon KL; Leung AKC; Ng WGG; Loo SK
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):27-37. PubMed ID: 30924425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of chronic urticaria.
    Kaplan AP; Greaves M
    Clin Exp Allergy; 2009 Jun; 39(6):777-87. PubMed ID: 19400905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.
    Altman K; Chang C
    Clin Rev Allergy Immunol; 2013 Aug; 45(1):47-62. PubMed ID: 22674016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H
    Chu CY; Al Hammadi A; Agmon-Levin N; Atakan N; Farag A; Arnaout RK; Kannenberg S; Kulthanan K; Mubarak A; Zaitoun F; Crowe S; Malfait S; Cooke K; Dekker EL
    World Allergy Organ J; 2020 Apr; 13(4):100117. PubMed ID: 32382379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
    Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
    Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inducible urticaria and chronic spontaneous urticaria].
    Du Thanh A
    Ann Dermatol Venereol; 2014 Nov; 141 Suppl 3():S570-9. PubMed ID: 25539678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity in chronic urticaria and urticarial vasculitis.
    Napoli DC; Freeman TM
    Curr Allergy Asthma Rep; 2001 Jul; 1(4):329-36. PubMed ID: 11892055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basophils and mast cells in chronic idiopathic urticaria.
    Vonakis BM; Saini SS
    Curr Allergy Asthma Rep; 2005 Jul; 5(4):270-6. PubMed ID: 15967067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria.
    Kaplan AP
    Allergy Asthma Proc; 2018 May; 39(3):184-190. PubMed ID: 29669665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab: a review of its use in patients with chronic spontaneous urticaria.
    McCormack PL
    Drugs; 2014 Sep; 74(14):1693-9. PubMed ID: 25217402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihistamines in urticaria.
    Ring J; Brockow K; Ollert M; Engst R
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():31-7. PubMed ID: 10209703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic urticaria: recent advances.
    Greaves MW; Tan KT
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):134-43. PubMed ID: 18094952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
    Kaplan AP; Giménez-Arnau AM; Saini SS
    Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.
    Hon KL; Li JTS; Leung AKC; Lee VWY
    Expert Opin Pharmacother; 2021 Mar; 22(4):497-509. PubMed ID: 32990110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urticaria and urticaria related skin condition/disease in children.
    Novembre E; Cianferoni A; Mori F; Barni S; Calogero C; Bernardini R; Di Grande L; Pucci N; Azzari C; Vierucci A
    Eur Ann Allergy Clin Immunol; 2008 May; 40(1):5-13. PubMed ID: 18700329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment.
    Türk M; Yılmaz İ; Nazik Bahçecioğlu S; Can P; Ertaş R; Kartal D; Çınar SL; Kocatürk E
    Dermatol Ther; 2021 Jan; 34(1):e14543. PubMed ID: 33190334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab may not inhibit mast cell and basophil activation in vitro.
    Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response.
    Gimeno R; Ribas-Llauradó C; Pesque D; Andrades E; Cenni B; Ambros B; Pujol R; Giménez-Arnau AM
    Clin Transl Allergy; 2023 Mar; 13(3):e12227. PubMed ID: 36973953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.